RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Stock

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Net Income 2024

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Net Income

25.49 M TRY

Ticker

ONCSM.E.IS

ISIN

TREONCO00026

In 2024, Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS's profit amounted to 25.49 M TRY, a -64.46% increase from the 71.73 M TRY profit recorded in the previous year.

The Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Net Income history

YEARNET INCOME (undefined TRY)
202225.49
202171.73
202018.71

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS’s growth potential.

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Revenue, EBIT and net profit per share

DateOncosem Onkolojik Sistemler Sanayi ve Ticaret AS RevenueOncosem Onkolojik Sistemler Sanayi ve Ticaret AS EBITOncosem Onkolojik Sistemler Sanayi ve Ticaret AS Net Income
2022140.53 M undefined31.96 M undefined25.49 M undefined
2021127.99 M undefined70.37 M undefined71.73 M undefined
2020101.3 M undefined28.84 M undefined18.71 M undefined

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS stock margins

The Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS's sales revenue. A higher gross margin percentage indicates that the Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Margin History

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Gross marginOncosem Onkolojik Sistemler Sanayi ve Ticaret AS Profit marginOncosem Onkolojik Sistemler Sanayi ve Ticaret AS EBIT marginOncosem Onkolojik Sistemler Sanayi ve Ticaret AS Profit margin
202243.62 %22.74 %18.14 %
202169.02 %54.98 %56.05 %
202037.79 %28.47 %18.47 %

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Aktienanalyse

What does Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS do?

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Net Income Details

Understanding Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS's Profit Margins

The profit margins of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.

Year-to-Year Comparison

Evaluating Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.

Impact on Investments

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.

Interpreting Profit Fluctuations

When Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.

Frequently Asked Questions about Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS stock

How much profit has Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS made this year?

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS has made 25.49 M TRY this year.

How has the profit developed compared to last year?

The profit has increased by -64.46% compared to last year fallen

What impact do the earnings have on the shareholders?

An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.

How does Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS publish its earnings?

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS publishes its earnings in the form of quarterly or annual reports.

Which financial indicators are included in the quarterly or annual reports?

The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.

Why is it important for investors to know the earnings of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS?

The profits of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.

How can one learn more about the earnings of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS?

You can learn more about the earnings of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS by reviewing the quarterly or annual reports or following the company presentations.

How much dividend does Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS pay?

Over the past 12 months, Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is expected to pay a dividend of 0 TRY.

What is the dividend yield of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS?

The current dividend yield of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is .

When does Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS pay dividends?

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS?

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS paid dividends every year for the past 0 years.

What is the dividend of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS?

For the upcoming 12 months, dividends amounting to 0 TRY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS located?

Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS is assigned to the 'Health' sector.

Wann musste ich die Aktien von Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS from 11/10/2023 amounting to 0.415 TRY, you needed to have the stock in your portfolio before the ex-date on 11/8/2023.

When did Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS pay the last dividend?

The last dividend was paid out on 11/10/2023.

What was the dividend of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS in the year 2023?

In the year 2023, Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS distributed 0 TRY as dividends.

In which currency does Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS pay out the dividend?

The dividends of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS are distributed in TRY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS

Our stock analysis for Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.